← Browse by Condition
Medical Condition
squamous cell carcinoma of head and neck
Total Trials
7
Recruiting Now
7
Trial Phases
Phase 1, Phase 1, Phase 2, Phase 2
ClinicalMetric tracks all active clinical trials for squamous cell carcinoma of head and neck sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — squamous cell carcinoma of head and neck Clinical Trials
How many clinical trials are currently recruiting for squamous cell carcinoma of head and neck?
ClinicalMetric currently tracks 7 actively recruiting clinical trials for squamous cell carcinoma of head and neck, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 7. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for squamous cell carcinoma of head and neck?
squamous cell carcinoma of head and neck research spans Phase 1 (4 trials), Phase 2 (3 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a squamous cell carcinoma of head and neck clinical trial?
Eligibility criteria for squamous cell carcinoma of head and neck trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 4
Phase 2 3
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT04389632 Phase 1
Recruiting
Enrollment
1,006 pts
Location
United States, Franc...
Sponsor
Seagen, a wholly owned subsidi...
NCT05086692 Phase 1, Phase 2
Recruiting
Enrollment
115 pts
Location
United States, Austr...
Sponsor
Medicenna Therapeutics, Inc.
NCT06085781
Recruiting
Enrollment
60 pts
Location
Canada
Sponsor
University Health Network, Tor...
NCT04429542 Phase 1
Recruiting
Enrollment
292 pts
Location
United States, Austr...
Sponsor
Bicara Therapeutics
NCT05280314 Phase 2
Recruiting
Enrollment
60 pts
Location
United States, Austr...
Sponsor
IO Biotech
NCT07419464 Phase 2
Recruiting
Enrollment
46 pts
Location
United States
Sponsor
Washington University School o...
NCT07219212 Phase 1
Recruiting
Enrollment
45 pts
Location
United States, Franc...
Sponsor
Johnson & Johnson Enterprise I...
Related Conditions
cutaneous squamous cell carcinoma (2) carcinoma non small cell lung (1) her2 negative breast neoplasms (1) esophageal squamous cell carcinoma (1) esophageal adenocarcinoma (1) gastroesophageal junction adenocarcinoma (1) ovarian neoplasms (1) cutaneous squamous cell cancer (1) exocrine pancreatic adenocarcinoma (1) urinary bladder neoplasms (1) uterine cervical neoplasms (1) stomach neoplasms (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology